Active Filter(s):
Details:
Under the terms of collaboration, Twist will leverage its proprietary Library to discover novel antibodies directed against Artisan’s immunotherapy targets. Artisan will leverage its Immune Cell Engineering Foundry and STAR Guides to develop custom cell therapeutics.
Lead Product(s): Cell Therapy
Therapeutic Area: Technology Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Cell and Gene therapy
Recipient: Twist Bioscience
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration January 25, 2022